The Sirtex Medical board has a tough call to make in coming weeks: back a higher, more complex takeover offer by Chinese private equity firm CDH Investments or go with the more secure, lower offer from a US trade player, Varian Medical Systems.
There is a lot to weigh up over the merits and risks of each bid, not just the cash price per share of $33.60 and $28, respectively.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
